All News about Avrobio Inc![]() ![]() ![]() ![]() Via Benzinga
![]() Via Benzinga
![]() Via Benzinga
![]() From AVROBIO, Inc.
Via Business Wire
![]() ![]() ![]() ![]() From AVROBIO, Inc.
Via Business Wire
![]() ![]()
Magenta Therapeutics' Shares Gain As FDA Signs Off Blood Cancer Candidate To Enter Human Trial
September 15, 2021
Via Benzinga
Exposures
Product Safety
![]()
AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 03, 2021
From AVROBIO, Inc.
Via Business Wire
![]()
AVROBIO to Participate at Four Upcoming Investor Conferences
September 01, 2021
From AVROBIO, Inc.
Via Business Wire
![]() ![]() ![]() Via Benzinga
![]() Via Benzinga
Exposures
Product Safety
![]() ![]() ![]() From AVROBIO, Inc.
Via Business Wire
![]() ![]() ![]() From AVROBIO, Inc.
Via Business Wire
![]() ![]() From AVROBIO, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Penticton Herald
Phone number: 250-492-4002
E-mail: csr@ok.bc.ca
Address: 186 Nanaimo Ave. W.
Penticton, BC V2A 1N4
© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.